TCL Archive DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program July 3, 1981
TCL Archive Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research August 3, 2012
TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research January 4, 1991
